The Demo Project

Phase:Demo Project
Principal Investigator(s):National Institute of Allergy and Infectious Diseases of the NIH
Objective:Aims to enroll 600 HIV-negative MSM and transgender women for PrEP regimen at City Clinic,  in Miami, and Whitman Walker Clinic.       **Results presented in July 2015 show high PrEP adherence and low HIV incidence. The study also showed that STIs were common among the participants, though STIs did not increase over the course of the study, highlighting the importance of STI screening and treatment among people using PrEP.**
Prevention Option(s):PrEP
Study Design:Controlled
Arms and Assigned Interventions
DescriptionAims to enroll 300 HIV-negative MSM and transgender women at City Clinic, while a sister project in Miami will enroll 200 participants in a PrEP regimen. Whitman Walker Clinic in Washington, DC, will also be a site, aiming to enroll approximately 100 participants.
Mode of DeliveryTablet
Trial Sponsors: NIAID
Start Date
End Date
October 1, 2014
January 31, 2015
Age range: 18 Years ↔ any
Population:Gay and Bisexual Men Who Have Sex with Men